[Studies on beta-lactam antibiotics for medicinal purpose. XII. Synthesis and structure-activity relationships of 7 beta-[alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-substituted acetamido]-7 alpha-metoxycephalosporanic acids].

S. Takano,I. Takakura,H. Ochiai,K. Momonoi,K. Tanaka,H. Shibata,M. Komatsu,T. Yasuda,M. Tai,Y. Fukuoka,I. Saikawa

DOI: https://doi.org/10.1248/YAKUSHI1947.102.7_617

1982-07-01

Abstract:

What problem does this paper attempt to address?

[Progress of Clinical and Genetic Research on Distal Hereditary Motor Neuropathy].

Lanxiao Cao,Guohua Zhao

DOI: https://doi.org/10.3760/cma.j.issn.1003-9406.2019.11.021

2019-01-01

Abstract:Distal hereditary motor neuropathy (dHMN) is a group of clinically and genetically heterogeneous disorders characterized by progressive distal weakness and atrophy. The onset of dHMN is at mid-adulthood or early childhood, and the symptoms are mainly present in the lower limbs. Besides weakness and atrophy of distal limb muscles, some patients may develop bulbar paralysis, and some may also present with mild sensory disturbance. Decreased or absent tendon reflexes may be discovered. Electromyography may show neurogenic damages. Muscular biopsy may reveal neurogenic amyotrophy. An increasing number of genes have been associated with dHMN. Pathogenesis of dHMN may include formation of protein aggregates, impairment of autophagy pathway, RNA processing, translation synthesis, axonal transport, endoplasmic reticulum stress, calcium channel and neuroprotection. A review for recent progress made on clinical characterization and molecular genetics of dHMN is provided.
[A Genotyping Study of 13 Cases of Early-Onset Charcot-Marie-Tooth Disease].

Jia-Lu Xu,Yi Zhang,Cong-Ying Zhao,Pei-Fang Jiang,Zhe-Feng Yuan,Yong-Lin Yu,Zhe-Zhi Xia,Feng Gao

DOI: https://doi.org/10.7499/j.issn.1008-8830.2019.07.010

2019-01-01

Abstract:OBJECTIVE To study the clinical characteristics and genetic variation of early-onset Charcot-Marie-Tooth disease (CMT). METHODS Children with a clinical diagnosis of early-onset CMT were selected for the study. Relevant clinical data were collected, and electromyogram and CMT-related gene detection were performed and analyzed. RESULTS A total of 13 cases of early-onset CMT were enrolled, including 9 males (69%) and 4 females (31%). The mean age at consultation was 4.0±2.1 years. Among them, 12 children (92%) had an age of onset less than 2 years, 9 children (69%) were diagnosed with CMT type 1 (including 6 cases of Dejerine-Sottas syndrome), 1 child (8%) with intermediate form of CMT, and 3 children (23%) with CMT type 2. The genetic test results of these 13 children showed 6 cases (46%) of PMP22 duplication mutation, 3 cases (23%) of MPZ gene insertion mutation and point mutation, 3 cases (23%) of MFN2 gene point mutation, and 1 case (8%) of NEFL gene point mutation. Eleven cases (85%) carried known pathogenic mutations and 2 cases (15%) had novel mutations. The new variant c.394C>G (p.P132A) of the MPZ gene was rated as "possibly pathogenic" and the new variant c.326A>G (p.K109R) of the MFN2 gene was rated as "pathogenic". CONCLUSIONS Early-onset CMT is mainly caused by PMP22 gene duplication mutation and MPZ gene mutations. The clinical phenotype is mainly CMT type 1, among which Dejerine-Sottas syndrome accounts for a considerable proportion.
Author Response for "genetic Spectrum and Clinical Profiles in a Southeast Chinese Cohort of Charcot‐Marie‐Tooth Disease"

Cong-Xin Chen,Hai-Lin Dong,Qiao Wei,Li-Xi Li,Hao Yu,Jia-Qi Li,Gong-Lu Liu,Hong-Fu Li,Ge Bai,Huan Ma,Zhi-Ying Wu

DOI: https://doi.org/10.1111/cge.13616

2019-01-01

Clinical Genetics

Abstract:Charcot-Marie-Tooth (CMT) disease is a heterogeneous group of inherited sensorimotor neuropathies. To clarify the genetic spectrum and clinical profiles in Chinese CMT patients, we enrolled 150 unrelated CMT patients from southeast China. We performed multiplex ligation-dependent probe amplification (MLPA) testing in all patients and next-generation sequencing (NGS) among those patients without PMP22 rearrangements. We identified PMP22 duplications in 40 patients and deletions in 12 patients. In addition, we found 19 novel variants and 36 known mutations in 57 patients. Among these 55 variants, 45 pathogenic or likely pathogenic variants were identified in 48 cases, and 10 variants with uncertain significance were identified in 9 cases. Therefore, we obtained a genetic diagnosis in 63.8% (88/138) of CMT patients and 66.7% (100/150) of all included patients. PMP22, GJB1, and MFN2 are the most common causative genes in CMT1 (demyelinated form), intermediate CMT, and CMT2 (axonal form), respectively. In this study, we identified a higher proportion of intermediate CMT, a relatively high frequency of NDRG1 mutations and clinical features of later onset age in CMT1A patients. Our results broaden the genetic and clinical spectrum of CMT patients, which can help optimize the genetic and clinical diagnosis.
Mutation Analysis of the Small Heat Shock Protein 27 Gene in Chinese Patients with Charcot-Marie-Tooth Disease

BS Tang,XM Liu,GH Zhao,W Luo,K Xia,Q Pan,F Cai,ZM Hu,C Zhang,B Chen,FF Zhang,L Shen,RX Zhang,H Jiang

DOI: https://doi.org/10.1001/archneur.62.8.1201

2005-01-01

Abstract:Background: Charcot-Marie-Tooth (CMT) disease, the most common hereditary peripheral neuropathy, is highly clinically and genetically heterogeneous, and mutations in at least 18 genes have been identified. Recently, mutations in small heat shock protein 27 (Hsp27) were reported to cause CMT disease type 2F and distal hereditary motor neuropathy.Objective: To investigate the frequency and phenotypic features of an Hsp27 mutation in Chinese patients with CMT disease.Design: DNA samples from 114 unrelated patients with CMT disease were screened for mutations in Hsp27 by polymerase chain reaction and direct sequencing. A cosegregated study was performed using the Mbil restriction endonuclease, and 50 healthy control subjects were analyzed. Haplotype analysis was performed using 5 short tandem repeat markers to analyze whether the families with the same mutation probably had a common ancestor.Results: One missense mutation, C379T, was detected in 4 autosomal dominant families with CMT'disease type 2, and haplotype analysis indicated that the 4 families probably had a common founder. The frequency of the Hsp27 mutation is 0.9% (1/111) in Chinese patients with CMT disease in our study, and the phenotypes were characterized by later onset (age, 35-60 years) and mild sensory impairments. Electrophysiological findings showed moderately to severely slowed nerve conduction velocities in lower limb nerves but normal or mildly reduced velocities in upper limb nerves.Conclusions: To our knowledge, this is the first report of an Hsp27 mutation in the People's Republic of China. The C379T mutation in Hsp27 also causes CMT disease type 2, except for distal hereditary motor neuropathy, and the phenotypes are distinct from the family with CMT disease type 2F described previously. A mutation of Hsp27 maybe uncommon in Chinese patients with CMT disease.
[Clinical, Pathological and Genetic Characteristics of 8 Patients with Distal Hereditary Motor Neuropathy].

M G Liu,P Fang,Y Wang,L Cong,Y,Y Yuan,Y Xu,J Zhang,D J Hong

DOI: https://doi.org/10.19723/j.issn.1671-167x.2021.05.025

2021-01-01

Abstract:OBJECTIVE:Distal hereditary motor neuropathy (dHMN) comprises a heterogeneous group of inherited disorders associated with neurodegeneration of motor nerves and neurons, mainly charac-terized by progressive atrophy and weakness of distal muscle without clinical or electrophysiological sensory abnormalities. To improve the recognition and diagnosis of the disease, we summarized the clinical manifestations, electrophysiological, pathological, and genetic characteristics in eight patients with dHMN.METHODS:Eight probands from different families diagnosed with dHMN were recruited in this study between June 2018 and April 2019 at Peking University People's Hospital. Eight patients underwent complete neurological examination and standard electrophysiological examinations. The clinical criteria were consistent with the patients presenting with a pure motor neuropathy with no sensory changes on electrophysiology. The detailed clinical symptoms, neurophysiological examinations, pathological features and gene mutations were analyzed retrospectively. Genetic testing was performed on the eight patients using targeted next-generation sequencing panel for inherited neuromuscular disorder and was combined with segregation analysis.RESULTS:The age of onset ranged between 11 and 64 years (median 39.5 years) in our dHMN patients. All the cases showed a slowly progressive disease course, mainly characterized by distal limb muscle weakness and atrophy. The motor nerve conduction revealed decreased compound muscle action potential amplitude and velocity, while the sensory nerve conduction velocities and action potentials were not affected. Needle electromyography indicated neurogenic chronic denervation in all patients. Muscle biopsy performed in two patients demonstrated neurogenic skeletal muscle damage. Sural nerve biopsy was performed in one patient, Semithin sections shows relatively normal density and structure of large myelinated fibers, except very few fibers with thin myelin sheaths, which suggested very mild sensory nerve involvement. Eight different genes known to be associated with dHMN were identified in the patients by next-generation sequencing, pathogenic dHMN mutations were identified in three genes, and the detection rate of confirmed genetic diagnosis of dHMN was 37.5% (3/8). Whereas five variants of uncertain significance (VUS) were identified, among which two novel variants co-segregated the phenotype.CONCLUSION:dHMN is a group of inherited peripheral neuropathies with great clinical and genetic heterogeneity. Next-generation sequencing is widely used to discover pathogenic genes in patients with dHMN, but more than half of the patients still remain genetically unknown.
Effect of Auditory Subliminal Stimulation on GSR

Hendrik F. Kotzé,A. T. Möller

DOI: https://doi.org/10.2466/pr0.1990.67.3.931

IF: 2.3

1990-12-01

Psychological Reports

Abstract:The present study was designed to investigate the possible effect of auditory subliminal stimulation on GSR. 38 undergraduate students were exposed subliminally to emotional words while GSR was monitored. The results confirmed the hypothesis that auditory subliminal stimulation would effect a significant increase in GSR.
[Analysis of the Pathological Features and Gene Mutations of Chinese Patients with Charcot-Marie-Tooth Disease].

Peng Guo,Bei-sha Tang,Guo-hua Zhao,Xiao-min Liu,Fu-feng Zhang,Ru-xu Zhang,Lu Shen,Hong Jiang,Jing-hui Liang

DOI: https://doi.org/10.3760/j:issn:0376-2491.2005.34.003

2005-01-01

Abstract:OBJECTIVE:To analyze the relationship of the pathological features and the gene mutations of Chinese patients with Charcot-Marie-Tooth disease.METHODS:The clinical manifestations and pathological investigations of 26 Chinese patients with Charcot-Marie-Tooth disease, 17 males and 9 females, aged 19.0 (4 - 49), with an average disease course of 0.5 - 30 years, 16 being with CMT1 type and 10 being with CMT2 type. Biopsy of sural nerve was conducted in 26 cases, and gene diagnosis was carried out in 13 cases.RESULTS:Five patients were with peripheral myelin protein-22 (PMP22) duplication, 4 of which showed demyelination, 4 of which showed incrassation of myelin sheath, and two of which showed "onion bulb" change without axonal denaturation. Four cases were with connexin 32 (Cx32) point mutations, 3 of which showed demyelination and one of which showed incrassation of myelin sheath and absence of axonal denaturation. The 2 patients with heat shock protein 22 (Hsp22) and heat shock protein 27 (Hsp27) point mutations both showed axonal atrophy, axonal loss and axonal regeneration.CONCLUSION:The pathological findings of the Chinese CMT patients performed by mutation screening were not completely consistent with the pathological features reported abroad. The results of the mutation screening are consistent with the pathological features; mutation screening has the character of high accuracy, little harm and helps diagnose early, so it is suggested to be performed widely clinically, especially to the patients who has family history or to their lineal relatives.
Analysis of the clinical, electrophysiological and histopathological features of Chinese Charcot-Marie Tooth disease patients with small heat-shock protein 27 gene mutation

Xiao-min LIU,Bei-sha TANG,Guo-hua ZHAO,Kun XIA,Fu-feng ZHANG,Xin-xiang Yan,Lan Xiao

DOI: https://doi.org/10.3760/j.issn:1006-7876.2005.05.003

2005-01-01

Abstract:ObjectiveTo analyze the features of the clinical manifestations, electrophysiological and histopathological investigations of Chinese Charcot-Marie-Tooth disease (CMT)patients with small heat-shock protein 27 (Hsp27) gene mutation.MethodsRetrospective analysis of the clinical manifestations and electrophysiological and histopathological investigations in 7 patients who came from 4 autosomal dominant CMT 2 families. These 4 families were caused by a same mutation C397T in Hsp27 gene and the haplotype analysis indicated they probably had a common founder.ResultsThe clinical manifestations of these patients were characterized by later onset (35 to 60 years old, 46.3±9.0 years averagely) and the duration of the disease was 17.6±6.6 years. Patients required a walking stick after an age of 12.6±4.9 years and required a wheelchair after 20.7±5.7 years after the onset. Patients showed mild sensory impairments. Electrophysiological findings showed moderately to severely slowed nerve conduction velocities (NCV) in lower limbs but normal or mildly reduced in upper limbs. A sural nerve biopsy was consistent with a chronic axonal neuropathy and muscle biopsy showed a neurogenic muscular atrophy.ConclusionsThe C379T mutation in Hsp27 gene might cause CMT2 beside distal hereditary motor neuropathy and the clinical manifestations were distinct from the CMT2F family reported previously, providing a further evidence for the clinical heterogeneity of CMT caused by the same mutation or by different mutations in the same gene.
The characteristics of gene mutations in Chinese patients with Charcot-Marie-Tooth disease]

Fu-feng Zhang,Bei-sha Tang,Guo-hua Zhao,Wei Luo,Kun Xia,Xiao-min Liu,Jian-feng Xiao,Ru-xu Zhang,Biao Chen,Cheng Hang,Qian Pan,Fang Cai,Peng Guo

DOI: https://doi.org/10.3760/j:issn:0376-2491.2005.26.004

2005-01-01

Abstract:To study the characteristics of gene mutations in Chinese patients with Charcot-Marie-Tooth disease (CMT).Real-time quantitative PCR, PCR-SSCP, and/or direct sequencing were used to analyze the mutation of the pathogenic genes PMP22, MPZ, CX32, EGR2, GDAP1, NEFL, HSP22 and HSP27 in 113 probands of CMT families, 45 of which had family history, from different provinces in China. The whole family members of the subjects with abnormal electrophoretic bands and 50 normal controls underwent the same examination.Thirty-six cases of PMP22 duplication, 7 cases of CX32 mutation, 1 case of HSP22 mutation, 1 case of HSP27 mutation, 1 case of MPZ mutation, and 1 case of GDAP1 mutation were found in the 113 CMT probands. No point mutation was found in PMP22, EGR2 and NEFL genes.Among the Chinese CMT patients 31.9% are caused by PMP22 duplication, 6.2% by CX32, and 0.9% by HSP22, HSP27, MPZ and GDAP1. Point mutations of PMP22, EGR2 and NEFL are rare.
The distal hereditary motor neuropathies

Alexander M Rossor,Bernadett Kalmar,Linda Greensmith,Mary M Reilly

DOI: https://doi.org/10.1136/jnnp-2011-300952

2011-10-25

Abstract:The distal hereditary motor neuropathies (dHMN) comprise a heterogeneous group of diseases that share the common feature of a length-dependent predominantly motor neuropathy. Many forms of dHMN have minor sensory abnormalities and/or a significant upper-motor-neuron component, and there is often an overlap with the axonal forms of Charcot-Marie-Tooth disease (CMT2) and with juvenile forms of amyotrophic lateral sclerosis and hereditary spastic paraplegia. Eleven causative genes and four loci have been identified with autosomal dominant, recessive and X-linked patterns of inheritance. Despite advances in the identification of novel gene mutations, 80% of patients with dHMN have a mutation in an as-yet undiscovered gene. The causative genes have implicated proteins with diverse functions such as protein misfolding (HSPB1, HSPB8, BSCL2), RNA metabolism (IGHMBP2, SETX, GARS), axonal transport (HSPB1, DYNC1H1, DCTN1) and cation-channel dysfunction (ATP7A and TRPV4) in motor-nerve disease. This review will summarise the clinical features of the different subtypes of dHMN to help focus genetic testing for the practising clinician. It will also review the neuroscience that underpins our current understanding of how these mutations lead to a motor-specific neuropathy and highlight potential therapeutic strategies. An understanding of the functional consequences of gene mutations will become increasingly important with the advent of next-generation sequencing and the need to determine the pathogenicity of large amounts of individual genetic data.

surgery,psychiatry,clinical neurology
[Genetic distribution in Chinese patients with hereditary peripheral neuropathy]

X X Liu,X H Duan,S Zhang,A P Sun,Y S Zhang,D S Fan

DOI: https://doi.org/10.19723/j.issn.1671-167X.2022.05.015

2022-10-18

Abstract:Objective: To analyze the distribution characteristics of hereditary peripheral neuropathy (HPN) pathogenic genes in Chinese Han population, and to explore the potential pathogenesis and treatment prospects of HPN and related diseases. Methods: Six hundred and fifty-six index patients with HPN were enrolled in Peking University Third Hospital and China-Japan Friendship Hospital from January 2007 to May 2022. The PMP22 duplication and deletion mutations were screened and validated by multiplex ligation probe amplification technique. The next-generation sequencing gene panel or whole exome sequencing was used, and the suspected genes were validated by Sanger sequencing. Results: Charcot-Marie-Tooth (CMT) accounted for 74.3% (495/666) of the patients with HPN, of whom 69.1% (342/495) were genetically confirmed. The most common genes of CMT were PMP22 duplication, MFN2 and GJB1 mutations, which accounted for 71.3% (244/342) of the patients with genetically confirmed CMT. Hereditary motor neuropathy (HMN) accounted for 16.1% (107/666) of HPN, and 43% (46/107) of HPN was genetically confirmed. The most common genes of HMN were HSPB1, aminoacyl tRNA synthetases and SORD mutations, which accounted for 56.5% (26/46) of the patients with genetically confirmed HMN. Most genes associated with HMN could cause different phenotypes. HMN and CMT shared many genes (e.g. HSPB1, GARS, IGHMBP2). Some genes associated with dHMN-plus shared genes associated with amyotrophic lateral sclerosis (KIF5A, FIG4, DCTN1, SETX, VRK1), hereditary spastic paraplegia (KIF5A, ZFYVE26, BSCL2) and spinal muscular atrophy (MORC2, IGHMBP, DNAJB2), suggesting that HMN was a continuum rather than a distinct entity. Hereditary sensor and autosomal neuropathy (HSAN) accounted for a small proportion of 2.6% (17/666) in HPN. The most common pathogenic gene was SPTLC1 mutation. TTR was the main gene causing hereditary amyloid peripheral neuropathy. The most common types of gene mutations were p.A117S and p.V50M. The symptoms were characterized by late-onset and prominent autonomic nerve involvement. Conclusion: CMT and HMN are the most common diseases of HPN. There is a large overlap between HMN and motor-CMT2 pathogenic genes, and some HMN pathogenic genes overlap with amyotrophic lateral sclerosis, hereditary spastic hemiplegia and spinal muscular atrophy, suggesting that there may be a potential common pathogenic pathway between different diseases.
Behavioral problems of adolescents with chronic physical illness: A comparison of parent-report and self-report measures

M. Stawski,J. Auerbach,M. Barasch,Y. Lerner,R. Zimin,Mervin S. Miller

DOI: https://doi.org/10.1007/BF01987962

Abstract:
Distal hereditary motor neuropathies

Meriem Tazir,Sonia Nouioua

DOI: https://doi.org/10.1016/j.neurol.2023.09.005

IF: 4.313

2024-05-05

Revue Neurologique

Abstract:Distal hereditary motor neuropathies (dHMN) are a group of heterogeneous hereditary disorders characterized by a slowly progressive distal pure motor neuropathy. Electrophysiology, with normal motor and sensory conduction velocities, can suggest the diagnosis of dHMN and guide the genetic study. More than thirty genes are currently associated with HMNs, but around 60 to 70% of cases of dHMN remain uncharacterized genetically. Recent cohort studies showed that HSPB1 , GARS , BICB2 and DNAJB2 are among the most frequent dHMN genes and that the prevalence of the disease was calculated as 2.14 and 2.3 per 100,000. The determination of the different genes involved in dHMNs made it possible to observe a genotypic overlap with some other neurogenetic disorders and other hereditary neuropathies such as CMT2, mainly with the HSPB1 , HSPB8 , BICD2 and TRPV4 genes of AD-inherited transmission and recently observed with SORD gene of AR transmission which seems relatively frequent and potentially curable. Distal hereditary motor neuropathy that predominates in the upper limbs is linked mainly to three genes: GARS , BSCL2 and REEP1 , whereas dHMN with vocal cord palsy is associated with SLC5A7 , DCTN1 and TRPV4 genes. Among the rare AR forms of dHMN like IGHMBP2 and DNAJB2 , the SIGMAR1 gene mutations as well as VRK1 variants are associated with a motor neuropathy phenotype often associated with upper motoneuron involvement. The differential diagnosis of these latter arises with juvenile forms of amyotrophic lateral sclerosis, that could be caused also by variations of these genes, as well as hereditary spastic paraplegia. A differential diagnosis of dHMN related to Brown Vialetto Van Laere syndrome due to riboflavin transporter deficiency is important to consider because of the therapeutic possibility.

clinical neurology
DNAJB2 C.184c>t Mutation Associated with Distal Hereditary Motor Neuropathy with Rimmed Vacuolar Myopathy

Meige Liu,Yan Xu,Daojun Hong,Lu Cong,Yangyi Fan,Jun Zhang

DOI: https://doi.org/10.5414/np301466

IF: 1.136

2022-01-01

Clinical Neuropathology

Abstract:Distal hereditary motor neuropathy (dHMN), also known as distal spinal muscular atrophy (dSMA), comprises a group of inherited peripheral neuropathies with great clinical and genetic heterogeneity, mainly characterized by progressive atrophy and weakness of distal muscle without clinical or electrophysiological sensory abnormalities. Next-generation sequencing is widely applied as an effective diagnostic technique to discover pathogenic genes in patients with dHMN. To date, at least 23 causal genes have been identified to be associated with dHMN, several of which encode chaperones. Here, we report a dHMN patient due to a homozygous c.184C>T variant in the DNAJB2 gene with rare neuropathic and myopathic characteristics on pathological examination. These findings might broaden the mutational spectrum of DNAJB2 and expand the tissue involvement of DNAJB2-related presentations.
Clinical and genetic spectra in a series of Chinese patients with Charcot–Marie–Tooth disease

Rui Wang,Jin He,Jin-Jing Li,Wang Ni,Zhi-Ying Wu,Wan-Jin Chen,Yi Wang

DOI: https://doi.org/10.1016/j.cca.2015.10.007

IF: 6.314

2015-01-01

Clinica Chimica Acta

Abstract:The aim of this study was to determine the clinical features and frequencies of genetic subtypes in a series of patients with Charcot–Marie–Tooth (CMT) disease from Eastern China. Patients were divided into three subtypes, CMT1, CMT2 and hereditary neuropathy with liability to pressure palsy (HNPP), according to their electrophysiological manifestations. Multiplex ligation-dependent probe analysis (MLPA) was performed to detect duplications/deletions in the PMP22 gene. The coding regions and splice sites of the GJB1, MPZ, MFN2 and GDAP-1 genes were determined by direct sequencing. Among the 148 patients in the study, 37.2% of the cases had mutations in genes assessed. The mutation detection rate was higher in patients with family histories than in spontaneous cases. PMP22 duplication (13.5%) was predominant in this group of patients, followed by PMP22 deletion (11.5%), and point mutations in GJB1 (8.8%), MPZ (2.0%) and MFN2 (0.7%). Three novel mutations (c.151T>C and c.310 A>G in GJB1 and c.1516 C>G in MFN2) were detected. A small deletion in PMP22 exon 4 was detected in a patient with severe CMT1. Genetic tests have great value in CMT patients with family histories. The frequency of PMP22 duplications was lower in Asian patients than in others. We suggest that genetic testing strategies in CMT patients should be primarily based on electromyography data.
Distal hereditary motor neuropathy type V: A report of a Chinese family

Bin Chen,RiLiang Zheng,XingHua Luan,Wei Zhang,Zhaoxia Wang,Yun Yuan

2008-01-01

Abstract:Objective: To report the clinical, pathological and genetic features in a Chinese family with distal hereditary motor neuropathy type V (dHMN-V). Methods: Four men and 5 women in 4 generations were involved. The onset of disease was from 13 to 40 years old. Six of them showed predominantly weakness of low extremities. Two women had only weakness and atrophy of hand muscle and 1 woman presented additionally pyramidal signs. The proband, a 20 year-old girl, presented asymmetrical atrophy and weakness of both hands since 13 years old. She had weakness of low extremities after 15 years old. Neurogenic changes were observed in the electromyography. Amplitude of compound muscle action potentials were markedly reduced, while the motor nerve conduction velocity were mildly decreased. Sensory nerve conduction velocity and amplitude of action potential were within the normal range. Sural nerve biopsy was performed in the proband. Berardinelli-Seip congenital lipodystrophy 2 (BSCL2) gene were sequenced in the proband and other 4 patients. Results: Nerve biopsy showed mild loss of myelinated fibers with a few regeneration cluster of myelinated fibers. DNA analysis revealed a heterozygous 263A→G mutation in exon 3 of BSCL2 gene. Conclusions: dHMN-V has been genetically and clinically confirmed in this family. The phynotype is obviously heterogeneous in onset time and clinical symptoms within the same family. The patients present mild pyramidal tract signs and axonal lesions in the sensory nerve.
Clinical and Genetic Diversity of PMP22 Mutations in a Large Cohort of Chinese Patients with Charcot-Marie-Tooth Disease.

Xiaoxuan Liu,Xiaohui Duan,Yingshuang Zhang,Dongsheng Fan

DOI: https://doi.org/10.3389/fneur.2020.00630

IF: 3.4

2020-01-01

Frontiers in Neurology

Abstract:Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous group of inherited neuropathies. The purpose of this study is to identify the clinical and genetic diversity of peripheral myelin protein 22 (PMP22) in Chinese patients with CMT disease and evaluate their correlations with the clinical manifestations. Using the multiplex ligation-dependent probe amplification (MLPA) technique and Sanger sequencing of PMP22 in a cohort of 465 Chinese families between 2007 and 2019, we identified 137 pedigrees with PMP22 duplications (29.5%), 26 pedigrees with PMP22 deletions (5.6%), and 10 pedigrees with point mutations (2.2%). By comparing our data with the results from other CMT centers in China, we estimate that the frequency of PMP22 mutation in mainland China is ~23.3% (261/1120). We confirmed de novo mutations in 40% (4/10) of PMP22 point mutations. We have also identified two severely affected patients who are compound heterozygotes for recessive PMP22 mutations (novel mutation c.320-1 G>A and R157W mutation) and a 1.5 Mb deletion in 17p11.2-p12, suggesting that c.320-1 G>A might be another recessive allele contributing to DSS in addition to the T118M and R157W mutations. A de novo mutation of S79P in PMP22 was also identified concomitantly with the R94W mutation in mitofusin2 (MFN2). Our study highlights the phenotypic variability associated with PMP22 mutations in mainland China. The results provide valuable insights into the current strategy of genetic testing for CMT disease. NGS technology has increased the potential for efficient detection of variants of unknown significance (VUS) and concurrent causative genes. Greater cooperation between neurologists and molecular biologists is needed in future investigations.
The genetic distribution in Chinese patients with Charcot-Marie-Tooth diseases: a 14-year cohort study

刘小璇,孙阿萍,段晓慧,张英爽,樊东升

DOI: https://doi.org/10.3760/cma.j.cn113694-20211102-00762

2022-01-01

Abstract:Objective:To investigate the genetic distribution of pathogenic genes of Charcot-Marie-Tooth diseases (CMT) in Chinese Han population, and compare the similarity and difference with the data in Peking University Third Hospital in 2013.Methods:Five hundred and twenty families with CMT and related diseases in Peking University Third Hospital and China-Japan Friendship Hospital from January 2007 to March 2021 were collected. After peripheral myelin protein 22 (PMP22) gene duplication and deletion mutations were initially detected by multiple ligation probe amplification, the probands of these families were sequenced by next-generation sequencing (NGS) gene panel or whole exome sequencing, and validated by Sanger sequencing.Results:Among the 520 families, 336 CMT families were genetically confirmed, and the mutation detection rate increased from 48.6% (51/105) in 2013 to 64.6% (336/520) in 2021 (χ 2=9.54, P=0.003). Among them, 139 families had PMP22 gene duplication mutation (139/520, 26.7%), 46 families had gap junction beta-1 (GJB1) gene mutation (46/520, 8.8%), 26 families had mitofusin-2 (MFN2) gene mutation (26/520, 5.0%), 12 families had myelin protein zero (MPZ) gene mutation (12/520, 2.3%), 11 families had PMP22 gene point mutation (11/520, 2.1%), and 10 families had heat shock protein B1 gene mutation (10/520, 1.9%). There were 10 families with ganglioside induced differentiation associated protein 1 (GDAP1) gene mutation (10/520, 1.9%), 8 families with SH3 domain and tetratricopeptide repeats 2 (SH3TC2) gene mutation (8/520, 1.5%), 7 families with immunoglobulin mu DNA binding protein 2 (IGHMBP2) gene mutation (7/520, 1.3%), 6 families with MORC family CW-type zinc finger 2 (MORC2) gene mutation (6/520, 1.2%), 5 families with sorbitol dehydrogenase (SORD) gene mutation (5/520, 1.0%), 16 families with very rare gene mutation (16/520, 3.1%) and 184 families without genetic diagnosis (184/520, 35.4%). Conclusions:Compared with the results in 2013, the 3 most common genes affecting CMT were still PMP22, GJB1 and MFN2 genes, but the proportion difference of patients with MPZ gene mutation gradually decreased with other genes such as SH3TC2 and GDAP1 genes. The proportion of newly discovered CMT genes, such as MORC2 and SORD genes, was similar with IGHMBP2 gene, which should be paid more attention. NGS greatly improved the detection rate of CMT, especially for patients with autosomal recessive-CMT.
[Significance and control of postoperative circulation slow down in the lower extremity].

P. Matis,P. Pauschinger,H. Fischer

1973-03-09

Abstract:
[The Clinical Presentation and Gene Mutation of Probands in Chinese Patients with Charcot-Marie-Tooth Disease].

Xiaoxuan Liu,Dongsheng Fan,Shujuan Song

DOI: https://doi.org/10.3760/cma.j.issn.0578-1426.2015.07.011

2015-01-01

Abstract:OBJECTIVETo identify the gene mutation of Chinese Charcot-Marie-Tooth (CMT) pedigrees and investigate the association of gene mutation to the clinical manifestations and electrophysiology, and the underlying mechanisms.METHODSA total of 105 pedigrees with CMT in our hospital were enrolled from January, 2007 to December 2013. The clinical features, CMT neuropathy score (CMTNS) and electrophysiological data were collected. Gene mutations were analyzed using multiplex ligation-dependent probe amplification (MLPA) and Sanger gene sequencing.RESULTSWe found 31(29.5%) PMP22 duplication pedigrees, 8(7.6%) GJB1 mutation pedigrees, 4(3.8%) MFN2 mutation pedigrees, 4(3.8%) HSPB1 mutation pedigrees, 3(2.9%) MPZ mutation pedigrees and 1(1.0%) PMP22 mutation pedigree. In Chinese Han population, the proportion of PMP22 duplication was relatively lower than that in western countries and manifested with classical clinical characteristics of CMT. Subjects with axonal CMT often presented with isolated lower extremity injury and with central nervous system involvement. Hereditary motor neuropathy might be underestimated in clinical setting and should be differentiated from motor neuron disease.CONCLUSIONSThe gene frequency distribution in patients with CMT in Chinese Han population is different from that in patients from western countries. We should establish our own epidemiological data of CMT in Chinese Han population.

[Studies on beta-lactam antibiotics for medicinal purpose. XII. Synthesis and structure-activity relationships of 7 beta-[alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-substituted acetamido]-7 alpha-metoxycephalosporanic acids].

[Progress of Clinical and Genetic Research on Distal Hereditary Motor Neuropathy].

[A Genotyping Study of 13 Cases of Early-Onset Charcot-Marie-Tooth Disease].

Author Response for "genetic Spectrum and Clinical Profiles in a Southeast Chinese Cohort of Charcot‐Marie‐Tooth Disease"

Mutation Analysis of the Small Heat Shock Protein 27 Gene in Chinese Patients with Charcot-Marie-Tooth Disease

[Clinical, Pathological and Genetic Characteristics of 8 Patients with Distal Hereditary Motor Neuropathy].

Effect of Auditory Subliminal Stimulation on GSR

[Analysis of the Pathological Features and Gene Mutations of Chinese Patients with Charcot-Marie-Tooth Disease].

Analysis of the clinical, electrophysiological and histopathological features of Chinese Charcot-Marie Tooth disease patients with small heat-shock protein 27 gene mutation

The characteristics of gene mutations in Chinese patients with Charcot-Marie-Tooth disease]

The distal hereditary motor neuropathies

[Genetic distribution in Chinese patients with hereditary peripheral neuropathy]

Behavioral problems of adolescents with chronic physical illness: A comparison of parent-report and self-report measures

Distal hereditary motor neuropathies

DNAJB2 C.184c>t Mutation Associated with Distal Hereditary Motor Neuropathy with Rimmed Vacuolar Myopathy

Clinical and genetic spectra in a series of Chinese patients with Charcot–Marie–Tooth disease

Distal hereditary motor neuropathy type V: A report of a Chinese family

Clinical and Genetic Diversity of PMP22 Mutations in a Large Cohort of Chinese Patients with Charcot-Marie-Tooth Disease.

The genetic distribution in Chinese patients with Charcot-Marie-Tooth diseases: a 14-year cohort study

[Significance and control of postoperative circulation slow down in the lower extremity].

[The Clinical Presentation and Gene Mutation of Probands in Chinese Patients with Charcot-Marie-Tooth Disease].